Literature DB >> 25128265

A comparative morphological, electrophysiological and functional analysis of axon regeneration through peripheral nerve autografts genetically modified to overexpress BDNF, CNTF, GDNF, NGF, NT3 or VEGF.

Stefan A Hoyng1, Fred De Winter1, Sara Gnavi2, Ralph de Boer3, Lennard I Boon4, Laura M Korvers4, Martijn R Tannemaat5, Martijn J A Malessy1, Joost Verhaagen6.   

Abstract

The clinical outcome of microsurgical repair of an injured peripheral nerve with an autograft is suboptimal. A key question addressed here is: can axon regeneration through an autograft be further improved? In this article the impact of six neurotrophic factors (BDNF, CNTF, GDNF, NGF, NT3 or VEGF) on axon regeneration was compared after delivery to a 1cm long nerve autograft by gene therapy. To distinguish between early and late effects, regeneration was assessed at 2 and 20weeks post-surgery by histological, electrophysiological and functional analysis. BDNF, GDNF and NGF exhibited a spectrum of effects, including early stimulatory effects on axons entering the autograft and excessive axon growth and Schwann cell proliferation at 20weeks post-surgery. Persistent expression of these factors in autografts interfered with target cell reinnervation and functional recovery in a modality specific way. Autografts overexpressing VEGF displayed hypervascularization, while grafts transduced with CNTF and NT3 were indistinguishable from control grafts. These three factors did not have detectable pro-regenerative effects. In conclusion, autograft-based repair combined with gene therapy for three of the six growth factors investigated (BDNF, GDNF, NGF) showed considerable promise since these factors enhanced modality specific axon outgrowth in autografts. The remarkable and selective effects of BDNF, GDNF and NGF on motor or sensory regeneration will be exploited in future experiments that aim to carefully regulate their temporal and spatial expression since this has the potential to overcome the adverse effects on long-distance regeneration observed after uncontrolled delivery.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gene therapy; Neurotrophic factor; Peripheral nerve repair; Schwann cell; Viral vector

Mesh:

Substances:

Year:  2014        PMID: 25128265     DOI: 10.1016/j.expneurol.2014.08.002

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  33 in total

1.  Surgical angiogenesis modifies the cellular environment of nerve allografts in a rat sciatic nerve defect model.

Authors:  Tiam M Saffari; Amr Badreldin; Femke Mathot; Leila Bagheri; Allen T Bishop; Andre J van Wijnen; Alexander Y Shin
Journal:  Gene       Date:  2020-04-27       Impact factor: 3.688

2.  Local delivery of the Neuregulin1 receptor ecto-domain (ecto-ErbB4) has a positive effect on regenerated nerve fiber maturation.

Authors:  G Gambarotta; D Pascal; G Ronchi; M Morano; S B Jager; S Moimas; L Zentilin; M Giacca; I Perroteau; P Tos; S Geuna; S Raimondo
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

3.  Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors.

Authors:  S A Hoyng; F De Winter; S Gnavi; L van Egmond; C L Attwell; M R Tannemaat; J Verhaagen; M J A Malessy
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

4.  Finely Tuned Temporal and Spatial Delivery of GDNF Promotes Enhanced Nerve Regeneration in a Long Nerve Defect Model.

Authors:  Laura M Marquardt; Xueping Ee; Nisha Iyer; Daniel Hunter; Susan E Mackinnon; Matthew D Wood; Shelly E Sakiyama-Elbert
Journal:  Tissue Eng Part A       Date:  2015-12       Impact factor: 3.845

5.  Neurogenic potential of engineered mesenchymal stem cells overexpressing VEGF.

Authors:  Alan J Man; Gregory Kujawski; Travis S Burns; Elaine N Miller; Fernando A Fierro; J Kent Leach; Peter Bannerman
Journal:  Cell Mol Bioeng       Date:  2016-01-13       Impact factor: 2.321

6.  The Differentiation of Skin Mesenchymal Stem Cells Towards a Schwann Cell Phenotype: Impact of Sigma-1 Receptor Activation.

Authors:  L Saulite; E Vavers; L Zvejniece; M Dambrova; U Riekstina
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

7.  Activating Injury-Responsive Genes with Hypoxia Enhances Axon Regeneration through Neuronal HIF-1α.

Authors:  Yongcheol Cho; Jung Eun Shin; Eric Edward Ewan; Young Mi Oh; Wolfgang Pita-Thomas; Valeria Cavalli
Journal:  Neuron       Date:  2015-10-29       Impact factor: 17.173

8.  Polycomb repression regulates Schwann cell proliferation and axon regeneration after nerve injury.

Authors:  Ki H Ma; Phu Duong; John J Moran; Nabil Junaidi; John Svaren
Journal:  Glia       Date:  2018-10-11       Impact factor: 7.452

9.  Increased Expression of Transcription Factor SRY-box-Containing Gene 11 (Sox11) Enhances Neurite Growth by Regulating Neurotrophic Factor Responsiveness.

Authors:  Michael P Jankowski; Lauren Miller; H Richard Koerber
Journal:  Neuroscience       Date:  2018-05-08       Impact factor: 3.590

10.  Baicalin promotes the viability of Schwann cells in vitro by regulating neurotrophic factors.

Authors:  Wenpu Zuo; Huayu Wu; Kun Zhang; Peizhen Lv; Fuben Xu; Weizhe Jiang; Li Zheng; Jinmin Zhao
Journal:  Exp Ther Med       Date:  2017-05-31       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.